Dynamic Variation of Impedance Cardiography(DYVIC) as a Diagnostic Tool of Acute Heart Failure (AHF)
DYVIC
1 other identifier
interventional
290
1 country
1
Brief Summary
Dynamic variations of bio-impedance measured cardiac output using non pharmacologic intervention (sitting position, passive leg rising and valsalva maneuver) could be used to detect acute heart failure in patients admitted to the ED for dyspnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2013
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedFirst Posted
Study publicly available on registry
August 7, 2017
CompletedAugust 2, 2021
October 1, 2020
5 months
September 7, 2013
July 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cardiac output rate measured by ICG before and during maneuvers in acute dyspneic patients between the AHF and non AHF groups
The diagnostic performance of each maneuver is evaluated by calculating the CO in ml/min by bio-impedance technique and compare the values between patients with and without AHF and between baseline. The diagnosis of AHF is based on clinical, biological (BNP levels), radiological (chest X-ray) and cardiac ultrasound data.
12 hours
Secondary Outcomes (1)
In hospital death
up to 10 days
Study Arms (4)
patients with acute dyspnea
EXPERIMENTALpatients presenting to the emergency department with acute onset dyspnea are assessed for acute heart failure using the bio impedance technology (BIOPAC system) to measure the cardiac output in different clinical situations. FIRST: the cardiac output (CO) is measured at the reference position. Inbetween each step the patient was put in the reference position during 5 minutes.
the sitting position
EXPERIMENTALthe patient is put at the sitting position and we measure the cardiac output by BIOPAC system (patient is put to a 90 degree sitting position during 1 to 2 minutes then the CO is measured 5 minutes later)
a passive leg rising maneuver
EXPERIMENTALwe make a passive leg rising and we measure the cardiac output by BIOPAC system (45 degree passive leg rising was done for 1 to 2 minutes and CO was measured during the maneuver 5minutes later.)
Valsalva maneuver
EXPERIMENTALthe patient was asked to perform the Valsalva maneuver and we measure the cardiac output by BIOPAC system(patients are asked to perform the Valsalva maneuver by executing a forced blow into a manometer for 30 seconds and the CO is calculated during this test.)
Interventions
patient is put in a 30 degree supine position during 5 minutes
patient is put to a 90 degree sitting position during 1 to 2 minutes then the CO is measured
patients are asked to perform the Valsalva maneuver by executing a forced blow into a manometer for 30 seconds and the CO is calculated during this test.
we make a passive leg rising and we measure the cardiac output by BIOPAC system (45 degree passive leg rising was done for 1 to 2 minutes and CO was measured during the maneuver.)
Eligibility Criteria
You may qualify if:
- year old or above
- non traumatic acute dyspnea
You may not qualify if:
- age \<18 years,
- cardio respiratory arrest,
- coma,
- shock,
- need for inotropic or vasoactive drugs,
- mechanical ventilation,
- severe and sustained rhythm disorders,
- severe mitral valve disease,
- severe pulmonary arterial hypertension
- renal insufficiency with creatinine\>150 μmol/l.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emergency Department
Monastir, 5000, Tunisia
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nouira Samir, Profesor
University hospital of Monastir
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 7, 2013
First Posted
August 7, 2017
Study Start
July 1, 2016
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
August 2, 2021
Record last verified: 2020-10